AstraZeneca Pharma India Balance Sheet Health
Financial Health criteria checks 5/6
AstraZeneca Pharma India has a total shareholder equity of ₹7.1B and total debt of ₹45.9M, which brings its debt-to-equity ratio to 0.6%. Its total assets and total liabilities are ₹10.8B and ₹3.7B respectively. AstraZeneca Pharma India's EBIT is ₹1.4B making its interest coverage ratio -4.5. It has cash and short-term investments of ₹5.1B.
Key information
0.6%
Debt to equity ratio
₹45.90m
Debt
| Interest coverage ratio | -4.5x |
| Cash | ₹5.06b |
| Equity | ₹7.12b |
| Total liabilities | ₹3.66b |
| Total assets | ₹10.78b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506820's short term assets (₹9.3B) exceed its short term liabilities (₹3.6B).
Long Term Liabilities: 506820's short term assets (₹9.3B) exceed its long term liabilities (₹89.9M).
Debt to Equity History and Analysis
Debt Level: 506820 has more cash than its total debt.
Reducing Debt: 506820's debt to equity ratio has increased from 0% to 0.6% over the past 5 years.
Debt Coverage: 506820's debt is well covered by operating cash flow (607.2%).
Interest Coverage: 506820 earns more interest than it pays, so coverage of interest payments is not a concern.